Evidence map›Paper›PMID 35783155›Full record

ArticleJournal of oncology2022

The Combined Clinical Diagnosis of TNF-

Junjie Jiang, Wei Zhang, Hui Liu, Yunyun Yang, Wei Zhang, Chunxia Zang

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Junjie JiangThyroid and Breast Dept 1, Extra-Thyroid and Breast Neoplasms 1, Cangzhou Central Hospital, Cangzhou, China.
Wei ZhangThyroid and Breast Dept 1, Extra-Thyroid and Breast Neoplasms 1, Cangzhou Central Hospital, Cangzhou, China.
Hui LiuThyroid and Breast Dept 1, Extra-Thyroid and Breast Neoplasms 1, Cangzhou Central Hospital, Cangzhou, China.
Yunyun YangOutpatient Comprehensive Treatment Room, Cangzhou Central Hospital, Cangzhou, China.
Wei ZhangThyroid and Breast Dept 1, Extra-Thyroid and Breast Neoplasms 1, Cangzhou Central Hospital, Cangzhou, China.
Chunxia ZangThyroid and Breast Dept 1, Extra-Thyroid and Breast Neoplasms 1, Cangzhou Central Hospital, Cangzhou, China.ORCID https://orcid.org/0000-0002-4547-7684
Cangzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To study the concentrations of tumor necrosis factor (TNF- Methods: 67 breast cancer patients who were treated in our hospital from January 2018 to September 2020 were set as the breast cancer group and were divided into stages I, II, III, and IV according to clinicopathology. In addition, 55 patients with benign breasts who were admitted to the hospital at the same time were selected as the benign breast group, and 60 healthy people in our hospital during the same period were selected as the healthy group. The differences between serum TNF- Results: Compared with the benign breast group and the healthy group, the serum levels of TNF- Conclusion: TNF-

Identifiers

PMID35783155
PMCPMC9242784
OpenAlexW4283376554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.